The masculinization programming window

Endocrine Development

Volumn 27, Issue , 2014, Pages 17-27

  Welsh, Michelle ^a   Suzuki, Hiroko ^b   Yamada, Gen ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; TESTOSTERONE;

ANOGENITAL DISTANCE; ARTICLE; AZOOSPERMIA; CLINICAL ASSESSMENT; CRYPTORCHISM; DISORDER OF SEX DEVELOPMENT; GESTATION PERIOD; GONAD DEVELOPMENT; HORMONAL REGULATION; HORMONE ACTION; HUMAN; HYPOSPADIAS; INCIDENCE; MASCULINIZATION PROGRAMMING WINDOW; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; SEX DIFFERENTIATION; SIGNAL TRANSDUCTION; TESTOSTERONE SYNTHESIS; TRANSGENIC MOUSE; ANIMAL; DISORDERS OF SEX DEVELOPMENT; FEMALE; MALE; MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY; TESTIS; TIME;

ANDROGENS; ANIMALS; DISORDERS OF SEX DEVELOPMENT; FEMALE; HUMANS; MALE; MICE; SEX DIFFERENTIATION; TESTIS; TIME FACTORS;

EID: 84930810987     PISSN: 14217082     EISSN: 16622979     Source Type: Book Series    
DOI: 10.1159/000363609     Document Type: Article

References (60)

1. Capel B: The battle of the sexes. Mech Dev 2000; 92: 89-103.
2. Jost A: A new look at the mechanisms controlling sex differentiation in mammals. Johns Hopkins Med J 1972; 130: 38-53.
3. Siiteri PK, Wilson JD: Testosterone formation and metabolism during male sexual differentiation in the human embryo. J Clin Endocrinol Metab 1974; 38: 113-125.
4. Habert R, Picon R: Testosterone, dihydrotestosterone and estradiol-17 beta levels in maternal and fetal plasma and in fetal testes in the rat. J Steroid Biochem 1984; 21: 193-198.
5. Welsh M, et al: Identification in rats of a programming window for reproductive tract masculinization, disruption of which leads to hypospadias and cryptorchidism. J Clin Invest 2008; 118: 1479-1490.
6. Reyes FI, Winter JS, Faiman C: Studies on human sexual development. I. Fetal gonadal and adrenal sex steroids. J Clin Endocrinol Metab 1973; 37: 74-78.
7. Jirasek JE: Morphogenesis of the genital system in the human. Birth Defects Orig Artic Ser 1977; 13: 13-39.
8. Staack A, et al: Mouse urogenital development: a practical approach. Differentiation 2003; 7102-413.
9. Marker PC, et al: Hormonal, cellular, and molecular control of prostatic development. Dev Biol 2003; 253: 165-174.
10. George FW, Wilson J: Gonads and ducts in mammals; in Knobil E, Neill JD (eds): The Physiology of Reproduction. New York, Raven Press, 1994, pp 3-27.
11. Wilson JD, George FW, Griffin JE: The hormonal control of sexual development. Science 1981; 211: 1278-1284.
12. MacLaughlin DT, Teixeira J, Donahoe PK: Perspective: reproductive tract development-new discoveries and future directions. Endocrinology 2001; 142: 2167-2172.
13. Yamada G, Satoh Y, Baskin LS, Cunha GR: Cellular and molecular mechanisms of development of the external genitalia. Differentiation 2003; 71: 445-460.
14. Yamada G, et al: Molecular genetic cascades for external genitalia formation: an emerging organogenesis program. Dev Dyn 2006; 235: 1738-1752.
15. Thankamony A, et al: Anogenital distance from birth to 2 years: a population study. Environ Health Perspect 2009; 117: 1786-1790.
16. Sharpe RM, Skakkebaek NE: Male reproductive disorders and the role of endocrine disruption: advances in understanding and identification of areas for future research. Pure Appl Chem 2003; 75: 2023-2038.
17. Imperato-McGinley J, et al: Comparison of the effects of the 5 alpha-reductase inhibitor finasteride and the antiandrogen flutamide on prostate and genital differentiation: dose-response studies. Endocrinology 1992; 131: 1149-1156.
18. McIntyre BS, Barlow NJ, Foster PM: Androgen-mediated development in male rat offspring exposed to flutamide in utero: permanence and correlation of early postnatal changes in anogenital distance and nipple retention with malformations in androgendependent tissues. Toxicol Sci 2001; 62: 236-249.
19. Welsh M, et al: Androgen-dependent mechanisms of Wolffian duct development and their perturbation by flutamide. Endocrinology 2006; 147: 4820-4830.
20. Silversides DW, Price CA, Cooke GM: Effects of short-term exposure to hydroxyflutamide in utero on the development of the reproductive tract in male mice. Can J Physiol Pharmacol 1995; 73: 1582-1588.
21. Foster PM, Harris MW: Changes in androgen-mediated reproductive development in male rat offspring following exposure to a single oral dose of flutamide at different gestational ages. Toxicol Sci 2005; 85: 1024-1032.
22. Clark RL, et al: Critical developmental periods for effects on male rat genitalia induced by finasteride, a 5α-reductase inhibitor. Toxicol Appl Pharmacol 1993; 119: 34-40.
23. Welsh M, Saunders PT, Sharpe RM: The critical time window for androgen-dependent development of the Wolffian duct in the rat. Endocrinology 2007; 148: 3185-3195.
24. van den Driesche S, et al: Inter-relationship between testicular dysgenesis and Leydig cell function in the masculinization programming window in the rat. PLoS One 2012; 7:e30111.
25. Spencer JR, et al: Effects of flutamide and finasteride on rat testicular descent. Endocrinology 1991; 129 741-748.
26. Inomata T, Eguchi Y, Nakamura T: Development of the external genitalia in rat fetuses. Jikken Dobutsu 1985; 34: 439-444.
27. Wilhelm D, Koopman P: The makings of maleness: towards an integrated view of male sexual development. Nat Rev Genet 2006; 7: 620-631.
28. Amann RP, Veeramachaneni DN: Cryptorchidism in common eutherian mammals. Reproduction 2007; 133: 541-561.
29. Husmann DA: Micropenis: an animal model and its human correlates. Adv Exp Med Biol 2002; 511: 41-56.
30. Baskin LS, et al: The effect of testosterone on androgen receptors and human penile growth. J Urol 1997; 158: 1113-1118.
31. Husmann DA, Cain MP: Microphallus: eventual phallic size is dependent on the timing of androgen dministration. J Urol 1994; 152: 734-739.
32. Macleod DJ, et al: Androgen action in the masculinization programming window and development of male reproductive organs. Int J Androl 2010; 33: 279-287.
33. Welsh M, et al: Critical androgen-sensitive periods of rat penis and clitoris development. Int J Androl 2010; 33:e144-e152.
34. Lee PA, Houk CP: Outcome studies among men with micropenis. J Pediatr Endocrinol Metab 2004; 17: 1043-1053.
35. Bin-Abbas B, et al: Congenital hypogonadotropic hypogonadism and micropenis: effect of testosterone treatment on adult penile size-why sex reversal is not indicated. J Pediatr 1999; 134: 579-583.
36. Wolf CJ, et al: Effects of prenatal testosterone propionate on the sexual development of male and female rats: a dose-response study. Toxicol Sci 2002; 65: 71-86.
37. Vainio S, et al: Female development in mammals is regulated by Wnt-4 signalling. Nature 1999; 397: 405-409.
38. Hughes IA: Congenital adrenal hyperplasia-a continuum of disorders. Lancet 1998; 352: 752-754.
39. Goy RW, Bercovitch FB, McBrair MC: Behavioral masculinization is independent of genital masculinization in prenatally androgenized female rhesus macaques. Horm Behav 1988; 22: 552-571.
40. Sir-Petermann T: Polycystic ovary syndrome, a pathway to type 2 diabetes. Nutrition 2005; 21: 1160-1163.
41. Swan SH, et al: Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ Health Perspect 2005; 113: 1056-1061.
42. Swan SH: Environmental phthalate exposure in relation to reproductive outcomes and other health endpoints in humans. Environ Res 2008; 108: 177-184.
43. Eisenberg ML, et al: The relationship between anogenital distance and azoospermia in adult men. Int J Androl 2012; 35: 726-730.
44. Hsieh MH, et al: Associations Among Hypospadias,Cryptorchidism, Anogenital Distance, and Endocrine Disruption. Current Urology Reports 2008; 9: 137-142.
45. Romano-Riquer SP, et al: Reliability and determinants of anogenital distance and penis dimensions in male newborns from Chiapas, Mexico. Paediatr Perinat Epidemiol 2007; 21: 219-228.
46. Bowman CJ, et al: Effects of in utero exposure to finasteride on androgen-dependent reproductive development in the male rat. Toxicol Sci 2003; 74: 393-406.
47. Eisenberg ML, Hsieh TC, Lipshultz LI: The relationship between anogenital distance and age. Andrology 2013; 1: 90-93.
48. Nishida H, et al: Positive regulation of steroidogenic acute regulatory protein gene expression through the interaction between Dlx and GATA-4 for testicular steroidogenesis. Endocrinology 2008; 149: 2090-2097.
49. Shima Y, et al: Contribution of Leydig and Sertolicells to testosterone production in mouse fetal testes.Mol Endocrinol 2013; 27: 63-73.
50. Yang JH, et al: Morphology of mouse external genitalia: implications for a role of estrogen in sexual dimorphism of the mouse genital tubercle. J Urol 2010; 184(4 suppl):1604-1609.
51. Dupont S, et al: Effect of single and compound knockouts of estrogen receptors α (ERα) and β (ERβ)on mouse reproductive phenotypes. Development 2000; 127: 4277-4291.
52. Matsumoto T, et al: Androgen receptor functions in male and female physiology. J Steroid Biochem Mol Biol 2008; 109: 236-241.
53. Matsumoto T, et al: Androgen receptor functions from reverse genetic models. J Steroid Biochem Mol Biol 2003; 85: 95-99.
54. Murashima A, et al: Essential roles of androgen signaling in Wolffian duct stabilization and epididymal cell differentiation. Endocrinology 2011; 152: 1640-1651.
55. Miyagawa S, et al: The role of Sonic hedgehog-Gli2 pathway in the masculinization of external genitalia. Endocrinology 2011; 152: 2894-2903.
56. Miyagawa S, et al: Genetic interactions of the androgen and Wnt/β-catenin pathways for the masculinization of external genitalia. Mol Endocrinol 2009; 23: 871-880.
57. Matsumaru D, et al: Genetic analysis of the role of Alx4 in the coordination of lower body and xternal genitalia formation. Eur J Hum Genet 2014; 22: 350-357.
58. Nishida H, et al: Gene expression analyses on embryonic external genitalia: identification of regulatory genes possibly involved in masculinization processes. Congenit Anom (Kyoto) 2008; 48: 63-67.
59. Haraguchi R, et al: Unique functions of Sonic hedgehog signaling during external genitalia development. Development 2001; 128: 4241-4250.
60. Villacorte M, et al: β-Catenin signaling regulates Foxa2 expression during endometrial hyperplasia formation. Oncogene 2013; 32: 3477-3482.